Intro

This chapter explores the properties and safety of psychedelic compounds like MDMA in mental health treatments. It highlights Atai Life Sciences' commitment to developing therapies for social anxiety and cognitive impairment, emphasizing the role of unexpected results in innovation.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app